Search Results - "Ruokonen, A"

Refine Results
  1. 1
  2. 2

    Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study by West, S., Lashen, H., Bloigu, A., Franks, S., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J.S., Morin-Papunen, L.

    Published in Human reproduction (Oxford) (10-10-2014)
    “…STUDY QUESTION Do teenage girls with a history of menstrual irregularity and/or elevated androgen levels in adolescence exhibit an increased risk of polycystic…”
    Get full text
    Journal Article
  3. 3

    How do changes in body mass index in infancy and childhood associate with cardiometabolic profile in adulthood? Findings from the Northern Finland Birth Cohort 1966 Study by Sovio, U, Kaakinen, M, Tzoulaki, I, Das, S, Ruokonen, A, Pouta, A, Hartikainen, A-L, Molitor, J, Järvelin, M-R

    Published in International Journal of Obesity (01-01-2014)
    “…Background/Objective: Postnatal growth patterns leading to obesity may have adverse influences on future cardiometabolic health. This study evaluated age and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study by Pinola, P., Morin-Papunen, L.C., Bloigu, A., Puukka, K., Ruokonen, A., Järvelin, M.-R., Franks, S., Tapanainen, J.S., Lashen, H.

    Published in Human reproduction (Oxford) (10-10-2014)
    “…STUDY QUESTIONS Can serum anti-Müllerian hormone (AMH) levels measured in female adolescents predict polycystic ovary syndrome (PCOS)-associated features in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study by Canoy, D, Barber, T M, Pouta, A, Hartikainen, A L, McCarthy, M I, Franks, S, Järvelin, M R, Tapanainen, J S, Ruokonen, A, Huhtaniemi, I T, Martikainen, H

    Published in European journal of endocrinology (01-06-2014)
    “…ObjectiveReduced sex hormone-binding globulin (SHBG) concentration predicts insulin resistance and type 2 diabetes, but its association with cardiovascular…”
    Get full text
    Journal Article
  8. 8

    Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study by Pinola, P., Lashen, H., Bloigu, A., Puukka, K., Ulmanen, M., Ruokonen, A., Martikainen, H., Pouta, A., Franks, S., Hartikainen, A.-L., Järvelin, M.-R., Morin-Papunen, L.

    Published in Human reproduction (Oxford) (01-11-2012)
    “…STUDY QUESTION Are self-reported menstrual disorders associated with hyperandrogenaemia and metabolic disturbances as early as in adolescence? SUMMARY ANSWER…”
    Get full text
    Journal Article
  9. 9

    Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome by Barber, T. M, Bennett, A. J, Groves, C. J, Sovio, U, Ruokonen, A, Martikainen, H, Pouta, A, Hartikainen, A.-L, Elliott, P, Lindgren, C. M, Freathy, R. M, Koch, K, Ouwehand, W. H, Karpe, F, Conway, G. S, Wass, J. A. H, Järvelin, M.-R, Franks, S, McCarthy, M. I

    Published in Diabetologia (01-07-2008)
    “…Aims/hypothesis Variants in the fat-mass and obesity-associated gene (FTO) influence susceptibility to type 2 diabetes via an effect on adiposity/obesity…”
    Get full text
    Journal Article
  10. 10

    Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes by Koivikko, M. L, Karsikas, M, Salmela, P. I, Tapanainen, J. S, Ruokonen, A, Seppänen, T, Huikuri, H. V, Perkiömäki, J. S

    Published in Diabetologia (01-03-2008)
    “…Aims/hypothesis Nocturnal hypoglycaemia may contribute to sudden death in diabetic patients. However, it is not well known why hypoglycaemia makes these…”
    Get full text
    Journal Article
  11. 11

    Pre-pregnancy overweight overtakes gestational diabetes as a risk factor for subsequent metabolic syndrome by Ijäs, H, Morin-Papunen, L, Keränen, A K, Bloigu, R, Ruokonen, A, Puukka, K, Ebeling, T, Raudaskoski, T, Vääräsmäki, M

    Published in European journal of endocrinology (01-11-2013)
    “…ObjectiveGestational diabetes mellitus (GDM) is associated with an increased risk of subsequent diabetes and metabolic syndrome (MS). The independent…”
    Get full text
    Journal Article
  12. 12

    Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study by Rautio, K., Tapanainen, J.S., Ruokonen, A., Morin-Papunen, L.C.

    Published in Human reproduction (Oxford) (01-06-2006)
    “…BACKGROUND: The objective of the study was to assess the therapeutic effects of rosiglitazone in overweight women with polycystic ovary syndrome (PCOS)…”
    Get full text
    Journal Article
  13. 13

    Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study by Koivunen, R., Pouta, A., Franks, S., Martikainen, H., Sovio, U., Hartikainen, A-L., McCarthy, M.I., Ruokonen, A., Bloigu, A., Järvelin, M-R., Morin-Papunen, L.

    Published in Human reproduction (Oxford) (01-09-2008)
    “…BACKGROUND Women with polycystic ovary syndrome (PCOS) suffer from anovulatory infertility and hospital-based studies suggest that they have an increased risk…”
    Get full text
    Journal Article
  14. 14

    Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms by LAITINEN, J, TAPONEN, S, JÄRVELIN, M. R, MARTIKAINEN, H, POUTA, A, MILLWOOD, I, HARTIKAINEN, A-L, RUOKONEN, A, SOVIO, U, MCCARTHY, M. I, FRANKS, S

    Published in International Journal of Obesity (01-06-2003)
    “…To study the association between body size from birth to adulthood and self-reported symptoms of polycystic ovary syndrome (PCOS), particularly hirsutism and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study by Morin-Papunen, Laure, Vauhkonen, Ilkka, Koivunen, Riitta, Ruokonen, Aimo, Martikainen, Hannu, Tapanainen, Juha S.

    “…Metformin, an insulin-sensitizing drug, has been shown to improve ovarian function and glucose metabolism in obese women with polycystic ovary syndrome (PCOS),…”
    Get full text
    Journal Article
  17. 17

    Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study by Majuri, A, Santaniemi, M, Rautio, K, Kunnari, A, Vartiainen, J, Ruokonen, A, Kesäniemi, Y A, Tapanainen, J S, Ukkola, O, Morin-Papunen, L

    Published in European journal of endocrinology (01-02-2007)
    “…Objective: Abdominal obesity, insulin resistance and compensatory hyperinsulinaemia play a central role in the pathogenesis of the polycystic ovary syndrome…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effects of metformin and ethinyl estradiol–cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome by Rautio, K, Tapanainen, J S, Ruokonen, A, Morin-Papunen, L C

    Published in European journal of endocrinology (01-02-2005)
    “…Objective: Women with polycystic ovary syndrome (PCOS) exhibit risk factors for cardiovascular diseases such as abdominal obesity, insulin resistance and…”
    Get full text
    Journal Article
  20. 20